Additionally, in the subcutaneous xenograft models, tumoral METTL3 inhibition and anti-PD-L1 therapy could both markedly limit tumor growth of the mice as compared to the control groups (Fig. 5c, Additional file 4: Fig. S4g, h). The gene discussed is CD274; the disease is neoplasm.